47 results on '"Nakatsuji, Hideaki"'
Search Results
2. Exercise attenuates polyglutamine‐mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy.
3. Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy
4. Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy
5. Visualized macrophage dynamics and significance of S100A8 in obese fat
6. Accumulation of adiponectin in inflamed adipose tissues of obese mice
7. The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Muscular Atrophy: A Case Report
8. High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics
9. Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics
10. Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q–adiponectin / total adiponectin ratio
11. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy
12. Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity
13. Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors
14. Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy
15. Src Inhibition Attenuates Polyglutamine-mediated Neuromuscular Degeneration in Spinal and Bulbar Muscular Atrophy (1854)
16. One-Year Reductions in Body Weight and Blood Pressure, but Not in Visceral Fat Accumulation and Adiponectin, Improve Urinary Albumin-to-Creatinine Ratio in Middle-Aged Japanese Men
17. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator
18. Hyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution
19. High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome
20. DNA methylation inhibitor attenuates polyglutamine‐induced neurodegeneration by regulating Hes5
21. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1
22. Overexpression of hepatocyte growth factor in SBMA model mice has an additive effect on combination therapy with castration
23. Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration
24. Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity
25. Carotid intima-media thickness, but not visceral fat area or adiponectin, correlates with intracoronary stenosis detected by multislice computed tomography in people with type 2 diabetes and hypertension
26. Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors
27. Tracing the movement of adiponectin in a parabiosis model of wild-type and adiponectin-knockout mice
28. Uric Acid Secretion from Adipose Tissue and Its Increase in Obesity
29. Adiponectin Protein Exists in Aortic Endothelial Cells
30. Correlation of circulating C1q and C1q-binding adiponectin concentrations with aging in males: a preliminary report
31. Serum C1q- binding adiponectin in maintenance hemodialysis patients
32. Three-month treatment with pioglitazone reduces circulating C1q-binding adiponectin complex to total-adiponectin ratio, without changes in body mass index, in people with type 2 diabetes
33. GOUT AND NUCLEIC ACID METABOLISM
34. High serum S100A8/A9 levels and high cardiovascular complication rate in type 2 diabetics with ultrasonographic low carotid plaque density
35. Metabolic syndrome correlates with polyvascular lesions detected by systemic vascular ultrasonography in Japanese people with type 2 diabetes
36. Contribution of glucocorticoid–mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction
37. High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice
38. Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes
39. Dynamic Changes of Adiponectin and S100A8 Levels by the Selective Peroxisome Proliferator–Activated Receptor-γ Agonist Rivoglitazone
40. Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes
41. Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men
42. Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells
43. Warfarin-induced Skin Necrosis and Venous Limb Gangrene: Lesson from a Case Induced the Serious Complications by the Anticoagulants During the Treatment of Acute Artery Occlusion
44. Acute Pulmonary Thromboembolism Immediate Aftermath of Childbirth in a Pregnant Patient with a Huge Uterine Myoma
45. Successful Surgical Treatment of an Infected Right Coronary Artery Aneurysm-to-Right Ventricle Fistula after Sirolimus-eluting Stent Implantation
46. Brugada syndrome in spinal and bulbar muscular atrophy.
47. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.